Description
GHK-Cu Capsules | Copper Peptide — Tissue Remodelling Research
GHK-Cu (Glycyl-L-Histidyl-L-Lysine:Cu²⁺) is a naturally occurring human plasma tripeptide-copper complex that was first isolated by Loren Pickart. It is one of the most biologically active signaling peptides known, regulating over 4,000 genes related to tissue repair, anti-inflammatory pathways, and antioxidant defence. These capsules (50mg per capsule, 60 capsules) extend the research utility of GHK-Cu into oral delivery models.
Mechanism of Action
- Collagen and ECM synthesis — upregulates collagen types I, II, III, and fibronectin in fibroblast models
- TGF-β/VEGF modulation — regulates transforming growth factor-beta and vascular endothelial growth factor expression
- Antioxidant gene induction — activates SOD1, catalase, and other reactive oxygen species scavenging pathways
- Anti-inflammatory — suppresses TNF-α, IL-6, and NF-κB in inflammatory cell models
Research Areas
GHK-Cu is studied in wound healing, skin biology, hair follicle research, neurodegeneration, COPD, and lung regeneration models. Frequently paired with BPC-157 and TB-500 in comprehensive tissue repair research panels.
For Research Use Only. Rainbow Peptide supplies this compound exclusively for in vitro and laboratory research purposes. Not for human or veterinary use.
Dr. M. Vasquez –
GHK-Cu capsules for our oral collagen synthesis and skin aging research. Content purity >99%. Capsule content uniformity excellent. COA comprehensive. Our oral model showed expected MMP modulation activity.
N. Ferrara –
50mg GHK-Cu capsules — ideal for our oral copper tripeptide bioavailability research. Content confirmed. COA detailed. Convenient format for skin and wound healing studies.
H. Brennan –
Good GHK-Cu capsules. Content >98.5% purity verified. Capsule uniformity within spec. COA thorough. Practical oral format for our dermal peptide research.